These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1555211)

  • 1. Antiphospholipid antibodies: is there a role in cardiac valvular disease and its thromboembolic complications?
    Nardone Soscia P; Romain PL
    Cardiology; 1992; 80(1):1-6. PubMed ID: 1555211
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiphospholipid antibodies in systemic lupus erythematosus.
    Ichikawa Y; Shimizu H; Moriuchi J; Uchiyama M; Takaya M; Arimori S; Kobayashi N; Watanabe K; Kawada T; Tanaka Y
    Tokai J Exp Clin Med; 1990 May; 15(2-3):241-4. PubMed ID: 2130530
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus.
    Khamashta MA; Cervera R; Asherson RA; Font J; Gil A; Coltart DJ; Vázquez JJ; Paré C; Ingelmo M; Oliver J
    Lancet; 1990 Jun; 335(8705):1541-4. PubMed ID: 1972484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid antibodies and "syndromes": many questions and few answers.
    Asherson RA
    Isr J Med Sci; 1990 May; 26(5):284-6. PubMed ID: 2116381
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antiphospholipid antibodies].
    Meurer M; Degitz K
    Hautarzt; 1992 Mar; 43(3):111-3. PubMed ID: 1577597
    [No Abstract]   [Full Text] [Related]  

  • 6. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus.
    Leung WH; Wong KL; Lau CP; Wong CK; Liu HW
    Am J Med; 1990 Oct; 89(4):411-9. PubMed ID: 2121029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thromboembolic complications in patients with systemic lupus erythematosus].
    Prudnikova LZ; Alekberova ZS; Nasonov EL; Vorob'ev PA; Sokolov VB
    Ter Arkh; 1989; 61(7):98-100. PubMed ID: 2511640
    [No Abstract]   [Full Text] [Related]  

  • 8. The relationship between the lupus anticoagulant, anticardiolipin antibodies and antiphospholipid antibodies.
    Tomer Y; Shoenfeld Y
    Isr J Med Sci; 1992 Jan; 28(1):38-40. PubMed ID: 1733897
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antiphospholipid antibodies and antiphospholipid syndrome in juvenile lupus erythematosus].
    Romicka AM; Gazda A; Zabek J; Wojciechowska B
    Pol Arch Med Wewn; 2006 May; 115(5):477-80. PubMed ID: 17195365
    [No Abstract]   [Full Text] [Related]  

  • 10. Cerebral and valve lesions in SLE: association with antiphospholipid antibodies.
    Asherson RA; Lubbe WF
    J Rheumatol; 1988 Apr; 15(4):539-43. PubMed ID: 3294408
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic and therapeutic problems in two patients with antiphospholipid antibodies, heart valve lesions, and transient ischaemic attacks.
    Asherson RA; Gibson DG; Evans DW; Baguley E; Hughes GR
    Ann Rheum Dis; 1988 Nov; 47(11):947-53. PubMed ID: 3144942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart valve disease in systemic lupus erythematosus. Role of antiphospholipid antibodies.
    Meyer O; Golstein M; Nicaise P; Labarre C; Kahn MF
    Clin Rev Allergy Immunol; 1995; 13(1):49-56. PubMed ID: 7648348
    [No Abstract]   [Full Text] [Related]  

  • 13. [The antiphospholipid antibody syndrome: a new clinical and therapeutic viewpoint in systemic lupus erythematosus].
    Bravo-Vargas G; Lavalle-Montalvo C
    Gac Med Mex; 1988; 124(1-2):39-42. PubMed ID: 3145236
    [No Abstract]   [Full Text] [Related]  

  • 14. The concomitant presence of lupus anticoagulant, anticardiolipin and anti-beta2-glycoprotein i antibodies could be associated with acquired activated protein c resistance in non-systemic lupus erythematosus patients.
    Gennari L; Blanco A; Alberto MF; Grosso S; Lazzari MA
    Br J Haematol; 2003 May; 121(3):527-9. PubMed ID: 12716380
    [No Abstract]   [Full Text] [Related]  

  • 15. The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional study.
    Long AA; Ginsberg JS; Brill-Edwards P; Johnston M; Turner C; Denburg JA; Bensen WG; Cividino A; Andrew M; Hirsh J
    Thromb Haemost; 1991 Nov; 66(5):520-4. PubMed ID: 1803614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiendothelial cell antibodies in patients with the antiphospholipid syndrome.
    Cervera R; Khamashta MA; Font J; Ramírez G; D'Cruz D; Montalbán J; López-Soto A; Asherson RA; Ingelmo M; Hughes GR
    Autoimmunity; 1991; 11(1):1-6. PubMed ID: 1812992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to types I and IV collagen and heart valve disease in systemic lupus erythematosus/antiphospholipid syndrome.
    Pardos-Gea J; Cortés-Hernández J; Castro-Marrero J; Balada E; Ordi-Ros J
    Clin Rheumatol; 2017 Jun; 36(6):1401-1406. PubMed ID: 28283766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies: a review.
    Harris EN; Gharavi AE; Asherson RA; Hughes GR
    Eur J Rheumatol Inflamm; 1984; 7(1):5-8. PubMed ID: 6443722
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombotic endocarditis and lupus anticoagulant. A pathogenetic possibility for idiopathic 'rheumatic type' valvular heart disease.
    Ford SE; Lillicrap D; Brunet D; Ford P
    Arch Pathol Lab Med; 1989 Apr; 113(4):350-3. PubMed ID: 2495783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiphospholipid syndrome: the clot thickens.
    Gleason CB; Harris EN
    J Ky Med Assoc; 1992 Jan; 90(1):11-7. PubMed ID: 1556471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.